Sanofi-Genzyme Bioventures is a corporate venture capital investment arm of Sanofi and is based in Cambridge, Massachusetts. The firm specializes in early stage and growth investments in the healthcare sectors including rare diseases, oncology, vaccines, breakthrough therapies like immunology, neurology, oncology, diabetes, and cardiovascular disease and digital health. It was founded in 2001.